Ledwoń Ewa, Zemła-Szten Paula, von dem Berge Thekla, Nalewajko Krzysztof, Passanisi Stefano, Piona Claudia, Dos Santos Tiago Jeronimo, Svensson Jannet, Korsgaard Berg Anna, Chobot Agata
Department of Pediatrics, University Clinical Hospital in Opole, 45-040 Opole, Poland.
Faculty of Health Sciences, University of Opole, 45-060 Opole, Poland.
Children (Basel). 2024 Jun 17;11(6):740. doi: 10.3390/children11060740.
The study aimed to estimate the prevalence of skin problems in children and adolescents with type 1 diabetes (T1D) using insulin pumps (IPs) and/or continuous glucose monitoring (CGM) in our center and analyze their association with various factors. As part of the international ISPAD JENIOUS-initiated SKIN-PEDIC project, we interviewed and examined patients who visited the regional pediatric diabetes center in Opole (Poland) for four weeks regarding the use of IP and/or CGM and the presence of skin problems. Body mass index (BMI) and glycemic parameters were obtained retrospectively from medical records. Among 115 individuals (45.2% girls, 83.5% IP users, 96.5% CGM users), old scars were the most common skin problem (IP users 53.1%; CGM users 66.4%), while ≥2 types of skin problems co-occurred (IP users 40.6%; CGM users 27.3%). Longer IP use was associated with a higher prevalence of skin problems (50% for IP < 1 year, 98.1%-IP 1-3 years, 100% for IP > 3 years; < 0.001), pointing out extra attention with IP use > 1 year. No significant associations were found between skin problems and gender, age, BMI centile and glycemic parameters. Dermatological complications were common among children using IP and CGM in our center, highlighting the need for vigilant monitoring and early intervention to manage these skin-related issues effectively.
本研究旨在评估在我们中心使用胰岛素泵(IP)和/或持续葡萄糖监测(CGM)的1型糖尿病(T1D)儿童和青少年皮肤问题的患病率,并分析其与各种因素的关联。作为国际小儿糖尿病研究组(ISPAD)发起的JENIOUS项目中SKIN-PEDIC项目的一部分,我们对前往波兰奥波莱地区儿科糖尿病中心就诊四周的患者进行了访谈和检查,内容涉及IP和/或CGM的使用情况以及皮肤问题的存在情况。体重指数(BMI)和血糖参数是从病历中回顾性获取的。在115名个体中(女孩占45.2%,IP使用者占83.5%,CGM使用者占96.5%),陈旧疤痕是最常见的皮肤问题(IP使用者中占53.1%;CGM使用者中占66.4%),而两种及以上类型的皮肤问题同时出现(IP使用者中占40.6%;CGM使用者中占27.3%)。IP使用时间越长,皮肤问题的患病率越高(IP使用<1年者为50%,IP使用1 - 3年者为98.1%,IP使用>3年者为100%;<0.001),这表明使用IP超过1年时需要格外关注。未发现皮肤问题与性别、年龄、BMI百分位数和血糖参数之间存在显著关联。在我们中心,使用IP和CGM的儿童中皮肤并发症很常见,这凸显了进行警惕监测和早期干预以有效管理这些皮肤相关问题的必要性。